跳至主要内容
临床试验/IRCT20200103045989N1
IRCT20200103045989N1招募中2 期

The efficacy of Compound Honey Syrup on Fractional Exhalation Nitric Oxide (FeNO) Changes, Pulmonary Symptoms and Body Mass Index (BMI) in Cystic Fibrosis Patients

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 no limit(—)
性别
All

入选标准

  • All patients with cystic fibrosis over 6 years who are able to perform FeNO test.

排除标准

  • Patients with cystic fibrosis under 6 years
  • Patients in need of hospitalization
  • Patients who have exacerbation (increased cough, sputum, fever and need to be hospitalized)
  • Patients with underlying diseases such as allergic bronchopulmonary aspergillosis, heart failure, tuberculosis
  • Patients with another acute illness during treatment
  • Patients who are allergic to any component of the compound honey syrup
  • Patients requesting exclusion
  • Patients unable to perform FeNO test.

研究者

相似试验